Stephanie Stadlin
Principal, Decision Resources Group
Stephanie Stadlin, Principal, Decision Resources Group, serves on Cancer Support Community’s Research and Training Institute Leadership Board.
Let Us Personalize Your Visit. You are:
If you've already saved your personalized content, login.
1421-1430 of 1972 results
Patricia Robinson, MD
Medical Oncologist, Loyola University Medical Center
Patricia Robinson, M.D., medical oncologist at Loyola University Medical Center, serves on Cancer Support Community’s Research and Training Institute Leadership Board.
Joe Mattingly, PhD, PharmD, MBA
Associate Professor, University of Maryland, School of Pharmacy
Joe Mattingly, Ph.D., PharmD, MBA, is a member of Cancer Support Community’s Research and Training Institute Leadership Board.
William Levin, MD
Medical Director, Global Network Operations Department of Radiation Oncology, Penn Medicine
William Levin, M.D., of Penn Medicine, is a member of Cancer Support Community’s Research and Training Institute Leadership Board.
Courtney Kronenthal, PhD
Genomes2People Research Program, Brigham and Women’s Hospital
Courtney Kronenthal, Ph.D., is a member of Cancer Support Community’s Research and Training Institute Leadership Board.
Diana Jeffery, PhD
Health Psychologist
Health psychologist Diana Jeffery, Ph.D., is a member of the Cancer Support Community’s Research and Training Institute Leadership Board.
Kelly Harris, MSS
CEO, Greater Philadelphia Cancer Support Community
Kelly Harris, CEO of Greater Philadelphia Cancer Support Community, serves on Cancer Support Community’s Research and Training Institute Leadership Board.
Mitch Golant, PhD
Fellow, American Psychosocial Oncology Society, Clinical Psychologist, A Professional Corporation
Mitch Golant, Ph.D., Fellow of the American Psychosocial Oncology Society, serves on Cancer Support Community’s Research and Training Institute Leadership Board.
Rebecca Cammy, MSW, LCSW
Supervisor, Oncology Support Services, Sidney Kimmel Cancer Center at Jefferson
Rebecca Cammy, MSW, LCSW, is a member of Cancer Support Community’s Research and Training Institute Leadership Board.
Expanding Access to Clinical Trials through the CLINICAL TREATMENT Act
Clinical trials are a promising avenue for expanding treatment options and extending survival for people with cancer. However, out-of-pocket costs associated with trial participation and gaps in insurance coverage create barriers for many cancer patients. The CLINICAL TREATMENT Act guarantees coverage of the routine care costs of clinical trial participation for Medicaid enrollees with life-threatening conditions, like cancer.